Fas / CD95 (蛋白 | 抗体 | cDNA 克隆 | ELISA 试剂盒)

All Fas / CD95 reagents are produced in house and quality controlled, including 24 Fas / CD95 Antibody, 2 Fas / CD95 ELISA, 52 Fas / CD95 Gene, 7 Fas / CD95 Lysate, 7 Fas / CD95 Protein, 3 Fas / CD95 qPCR. All Fas / CD95 reagents are ready to use.

Fas / CD95 Protein (7)

Fas / CD95 Antibody (24)

Fas / CD95 ELISA 试剂盒(即用型)& ELISA 抗体对套装(非即用型)(2)

Fas / CD95 cDNA Clone (52)

NM_000043.3

克隆载体 cDNA 产品

In lentiviral vector

NM_007987.1

克隆载体 cDNA 产品

In lentiviral vector

NM_139194.2

克隆载体 cDNA 产品

In lentiviral vector

NM_001032933.1

克隆载体 cDNA 产品

In lentiviral vector

Fas / CD95 Lysate (7)

更多受客户欢迎的产品

Fas / CD95 分子背景

CD95 (APO-1/Fas) is an important inducer of the extrinsic apoptosis signaling pathway and therapy induced apoptosis of many tumor cells has been linked to the activity of CD95. is a prototype death receptor characterized by the presence of an 8 amino acid death domain in its cytoplasmic tail. This domain is essential for the recruitment of a number of signaling components upon activation by either agonistic anti-CD95 antibodies or cognate CD95 ligand that initiate apoptosis. The complex of proteins that forms upon triggering of CD95 is called the death-inducting signaling complex (DISC). The DISC consists of an adaptor protein and initiator caspases and is essential for induction of apoptosis. CD95 is also crucial for the negative selection of B cells within the germinal center (GC). Impairment of CD95-mediated apoptosis results in defective affinity maturation and the persistence of autoreactive B-cell clones. Changes in the expression of CD95 and/or its ligand CD95L are frequently found in human cancer. The downregulation or mutation of CD95 has been proposed as a mechanism by which cancer cells avoid destruction by the immune system through reduced apoptosis sensitivity. Thus, CD95 has therefore been viewed as a tumor suppressor. CD95 has been reported to be involved in the activation of NF-kappaB, MAPK3/ERK1, MAPK8/JNK, and the alternate pathways for CTL-mediated cytotoxicity. Accordingly, this protein is implicated in the pathogenesis of various malignancies and diseases of the immune system. The CD95/CD95L system was implicated in the etiology of inflammatory bowel disease (IBD) based, primarily, on the finding that CD95 is highly expressed in the intestinal epithelial cells and that epithelial apoptosis is increased in IBD.

Fas / CD95 参考文献

  • Mschen M, et al. (2002) The origin of CD95-gene mutations in B-cell lymphoma. Trends Immunol. 23(2): 75-80.
  • Peter ME, et al. (2003) The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 10(1): 26-35.
  • Peter ME, et al. (2005) Does CD95 have tumor promoting activities Biochim Biophys Acta. 1755(1): 25-36.
  • Chen L, et al. (2010) Cell death in the colonic epithelium during inflammatory bowel diseases: CD95/Fas and beyond. Inflamm Bowel Dis. 16(6): 1071-6.